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ABSTRACT 
Objective: Serial Western Blot (WB) testing was utilized for the 
early diagnosis of neonatal HIV infection. 
Methods: Serum samples included five anti-HIV positive 
mother/child pairs and 57 newborns who received hepatitis B 
immunoglobulin and hepatitis B vaccine. Enzyme-linked 
immunosorbent assay (ELISA) and serial WB were supple- 
mented by polymerase chain reaction (PCR) and gag sequenc- 
ing studies. 
Results: Serial WB patterns between the five mothers and their 
newborns were initially identical. Reaction lines, however, 
declined progressively and proportionately in the three infants 
not HIV infected. Two newborns were diagnosed early to be 
HIV-positive by evaluating the intensifying and increasing WB 
reaction lines. For the group of newborns who underwent the 
hepatitis B control program, all WB reaction lines declined pro- 
gressively with time and none of these infants were truly HIV 
infected. 
Conclusion: Serial WB is simple and reliable and may be used 
for the early diagnosis of HIV infection in infants. 
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At the end of 1994 the World Health Organization (WHO) 
estimated that nearly 1.5 million children worldwide had 
been infected with the human immunodeficiency virus 
type 1 (HIV) by mother-to-child transmission. 1 The WHO 
also estimated that by the turn of the century at least 10 
million children would be HIV-infected.2 Although 
zidovudine therapy during pregnancy, at delivery, and 
during the neonatal period reduces the risk of vertical 
HIV infection,3 the incidence of neonatal infection is still 
expected to increase through the next decade as a result 
of increasing numbers of women with heterosexually 
acquired HIV infection. 1 Once immunologically imma- 
ture newborns are infected, many often rapidly develop 
acquired immunodeficiency syndrome (AIDS) and die 
before 5 years of age.1 Thus, early diagnosis and proper 
management of HIV infection in infants are imperative 
to delay the onset of symptoms and prolong survival. 
Screening for HIV infection is based on the detec- 
tion of antibodies in serum using the enzyme-linked 
immunosorbent assay (ELISA) and is usually supple- 
mented or confirmed by the Western Blot (WB) test. In 
adults and older children, HIV infection can be reliably 
and accurately diagnosed if both the ELISA and WB tests 
are positive. However, it has been previously reported 
that the interpretation of these tests in the first 15 to 18 
months of life is difficult because of the passive transfer 
of maternal antibodies across the placenta to the newborn.*z5 
In addition to the risk of HIV vertical transmission, 
Taiwan’s high prevalence of hepatitis B virus (HBV) infec- 
tion poses a unique additional potential for neonatal HIV 
infection.’ To reduce the risk of vertical HBV transmis- 
sion, an islandwide HBV control program, begun in 1984, 
provided for all newborns of HBV-carrier mothers to 
receive imported hepatitis B immunoglobulin (HBIG) fol- 
lowed by the hepatitis B vaccination.’ The HBIG was 
later found to be anti-HIV positive. As a result, concern 
about the safety of HBIG and hepatitis B vaccine with 
regard to potential HIV infection in newborns arose, and 
an investigation was begun to clarify the safety of the 
HBV control program.8-11 
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This report presents the use of serial WB pattern 
analyses as a method for the early diagnosis of HIV infec- 
tion in two groups of “at-risk” infants: those of HIV 
positive mothers and those who had received HBIG and 
hepatitis B vaccine. 
MATERIAL AND METHODS 
From May 1985 through December 1995, 904 HIV 
seropositive native Chinese were reported to the Depart- 
ment of Health of Taiwan. Each subject’s anti-HIV status 
was determined with ELISAs and supplemented with WB 
(DuPont and/or Pasteur) tests.iz Additional polymerase 
chain reaction (PCR) with GeneAmp kit and sequence 
studies of the gag gene by standard chain termination 
DNA protocols were carried out for each positive 
sample. I3 
Of the adult HIV-positive samples, 839 came from 
men and 65 from women. Five live full-term deliveries to 
HIV-positive women occurred between 1985 and 1995. 
Serum ELISA and WB tests for HIV were performed 
monthly for these newborns. 
Among the infants enrolled in the HBV control pro- 
gram, sera were collected at 3month intervals, resulting 
in a total of 211 samples from 57 infants.8~9 Supplemen- 
tal WB tests were performed for those with positive ELISA 
tests. 
To differentiate between passive seropositivity and 
true HIV infection, changes in WB reaction patterns were 
reviewed by the AIDS Advisory Committee of the Depart- 
ment of Health. A change in WB patterns was defined as 
one or both of the following: (1) an increase or reduc- 
tion in the number of reaction bands and/or (2) the dis- 
proportionate intensification or fading of one or more 
reaction bands over time.8-11 Neonatal HIV seropositivity 
was defmed as an increase in the number of WB reaction 
bands and/or the disproportionate intensification of reac- 
tion bands over time. 
RESULTS 
Tests at birth using cord blood from all five newborns of 
HIV-positive mothers demonstrated high ELISA readings 
and WB banding patterns that essentially corresponded 
to that of their respective mothers (Figure 1). As 
expected, the initial serum screening was unable to con- 
clusively differentiate between the passive transfer of 
maternal antibodies and the active production of anti- 
HIV by the newborns. The WB reaction lines of three 
newborns to HIV-positive mothers declined progressively 
and proportionately with time, thus falling into the HIV- 
negative category The number and intensity of the WB 
reaction lines in the other two newborns to HIV-positive 
mothers increased progressively and disproportionately 
Figure 1. Western Blot (Pasteur) in a family. A = Positive control pro- 
vided by the manufacturer; B = father (late stage AIDS); C = mother 
(asymptomatic); D, E = infant at 3 and 6 months of age, respectively. 
Band intensity ratios (e.g., p34:p25) in strips B and C are attributed to 
differences in disease staging and/or immune response to HIV infec- 
tion. IgG anti-HIV was passively transferred to the newborn and at 6 
months of age has nearly disappeared. Western Blot patterns of C, D, 
and E are internally proportionate, becoming progressively fainter, 
because the infant did not produce its own anti-HIV IgG. 
with time, falling into the HIV-positive by vertical trans- 
mission category (Figure 2). All initial diagnoses were 
verified by PCR and/or sequencing studies.13 
Among the hepatitis B control group, 18 infants had 
positive ELISA tests in at least one serial sample during 
the first year of life. The ELISA readings declined pro- 
gressively and the duration of seropositivity varied among 
the infants (Table 1). Initial WB patterns in these new- 
borns were the same as the WB patterns from corre- 
sponding batches of HBIG (Figure 3). As in the 
mother-to-newborn group, the initial serum WB test 
could not conclusively differentiate between the passive 
injection of anti-HIV-contaminated HBIG and the active 
production of immunoglobulin G (IgG) anti-HIV by the 
newborns. Follow-up studies of the sera from the HBV 
infant group showed progressively fewer reaction lines 
and a proportionate decline in the WB reactions over 
time. As such, no infant infected with HIV in the HBV 
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Figure 2. Western Blot (DuPont) on a mother-infant vertical trans- 
mission case. A = positive control provided by the manufacturer; B = 
negative control; C = weakly positive control; D, E, F = infant at 6, 7, 
and 8 months of age, respectively. G, H, I = HIV-positive mother at 6, 
7, and 8 months postpartum, respectively. Monthly WB tests of the 
infant showed progressively intensifying and increasing numbers of 
reaction lines. Band intensity ratios were different between D, E, and 
F, indicating that the infant was developing its own anti-HIV indepen- 
dent of potential maternal effects. Furthermore, WB pattern of the 
infant at 6 months (D) was noted to be different from that of the mother 
at 6 months postpartum (G), indicating a true case of vertical trans- 
mission. Maternal WB patterns did not change appreciably during the 
3-month follow-up. PCRs from both mother and infant were positive, 
and structural studies disclosed a new subtype of HIV gag sequence.13 
control program was detected. To date, none of the 
seropositive infants has exhibited signs or symptoms char- 
acteristic of AIDS. 
DISCUSSION 
In the 1990s women comprise the fastest growing group 
affected by the HIV/AIDS pandemic. Consequently, HIV 
infection in infants born to these women has also become 
an extremely challenging problem, especially in terms of 
detection, management, and care. The early diagnosis of 
HIV/AIDS in infants is necessary for proper management, 
to delay the onset of symptoms and prolong survival as 
well as to minimize potentially serious psychological, 
familial, social, and economic problems. 
Immunoglobulin G antibodies are transported freely 
across the placenta, and the initial antibody status of the 
newborn generally reflects that of the mother, since the 
goat anti-human antibody used in both the ELISA and WB 
tests is usually anti-IgG. This is problematic in establish- 
Figure 3. Western Blot (DuPont) patterns of an infant who received 
a HBIG injection. A = HBIG showed HIV-positive reaction patterns; B, 
C = infant at 3 and 6 months post-HBIG injection, respectively. The 
reaction lines faded proportionately from B to C indicating HBIG anti- 
HIV decayed or was catabolized by the infant. The infant did not pro- 
duce its own anti-HIV. 
ing an early diagnosis of HIV infection in newborns. 
Indeed, many countries follow Thailand’s 1995 guide- 
lines for HIV testing in infants that recommend a repeat 
of the antibody tests at 18 months.5 
Taiwan began the fast nationwide HBV control pro- 
gram in 1984, before HIV screening of blood products 
became widespread. Great concern later surfaced about 
the safety of both HBIG and HBV vaccine regarding the 
risk for HIV infection of those neonates included in the 
program. Therefore, both the AIDS Advisory and the HBV 
Control Committees proposed a rapid and reliable 
Table 1. Duration of Anti-HIV Seropositivity in Newborns Injected with Anti-HIV-Positive HBIG 
Number of Infants Seropositive at Age (Months) 
Number of Infants (n = 57) Doses of HBlG (mL) 3 (n = 7 1) 6 (n = 4) 12 (n = 3) 18 (n = 0) 24 (n = 0) 
27 0.25 7 2 2 0 0 
30 0.5 4 2 1 0 0 
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method for the early diagnosis of HIV infection in these 
neonates, using serial WEl assays.8-1i 
The detection of IgA anti-HIV antibodies was 
reported to be both sensitive and specific by the time 
an infant is 6 months of age1*J5; however, currently the 
widespread use of the IgA anti-HIV test is not readily 
available. The authors propose that an IgM anti-HIV test 
would be an earlier indicator of an infant’s HIV serosta- 
tus.8,9 In the past several years new virologic and immuno- 
logic techniques, such as viral cultures, detection of viral 
antigens, acid dissociation of immune complexes, and 
PCR have enabled the early diagnosis of HIV infection in 
infants born to HIV-positive mothers.4a16,17 However, many 
of these diagnostic measures are costly as well as time- 
and staff-intensive, thus limiting their universal 
application. 
Maternal IgG will gradually decay by itself or be 
catabolized by the infant, Accordingly, the decline in IgG 
anti-HIV antibodies shown in the WBs is generally inter- 
nally proportionate. *-11 Scientists and clinicians have gen- 
erally recommended an l&month wait to accurately 
detect anti-HIV produced by the infant independent of 
maternal antibodies. 4,5 In the present study group of 
infants enrolled in the HBV control program, donor IgG 
antibodies did not persist for more than 12 months (see 
Table 1). This observation may be attributed to the fact 
that the amount of IgG anti-HIV antibodies contained in 
HBIG is relatively low compared to the IgG anti-HIV that 
is passively transferred from the mothers. 
The coexistence of a heterogeneous HIV population 
in the mother and a relatively homogeneous population 
of HIV in the newborn is a biologic phenomenon that 
results from different immune responses to HIV infec- 
tion. Consequently, as the infant matures, the HIV will 
mutate leading to an internally disproportionate intensi- 
fication of WI3 reaction patterns and increasing numbers 
of lines (see Figure 2). 
This study is limited by the small number of infants 
born to HIV-positive mothers. As a result, fmdings may 
not necessarily be genera&able to all cases of babies 
born to HIV-positive women. Despite this limitation, the 
conclusions generated from this study provide an impor- 
tant foundation for further large-scale studies of serial 
WB analyses for the early detection of HIV infection in 
newborns. Its simplicity and cost-effectiveness allow it 
to be readily adapted for the early diagnosis of HIV infec- 
tion due to contaminated blood and blood-product trans- 
fusions as well as other routes of transmission. 
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